Similar Papers

Paper Title
Journal
Date
Author
Abstract 2351: Evaluation of KRAS and BRAF mutation analysis in primary metastatic colorectal cancers versus matched syn- and metachronous metastases
Wolfgang Dietmaier ... Alexander Kiesl
Cancer Research | VOL. 70
Wolfgang Dietmaier, et. al.Wolfgang Dietmaier ... Alexander Kiesl
15 Apr 2010
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease
Gemma Bruera ... Thierry Frébourg
BMC Medicine | VOL. 10
Gemma Bruera, et. al.Gemma Bruera ... Thierry Frébourg
08 Nov 2012
Abstract C35: Different prognostic relevance of KRAS genotype in metastatic colorectal cancer (MCRC) patients fitting for triplet chemotherapy plus VEGF-inhibitor, unfit for intensive medical treatment and post-progression.
Gemma Bruera ... Enrico Ricevuto
Molecular Cancer Therapeutics | VOL. 12
Gemma Bruera, et. al.Gemma Bruera ... Enrico Ricevuto
01 Nov 2013
Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.
Frank A Sinicrope ... Pashtoon M Kasi
Clinical Gastroenterology and Hepatology | VOL. 14
Frank A Sinicrope, et. al.Frank A Sinicrope ... Pashtoon M Kasi
09 Feb 2016
View more papers

More From: British Journal of Cancer

Paper Title
Journal
Date
Author
RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC.
Wei Zhang ... Huayue Lin
British journal of cancer | VOL. -
Wei Zhang, et. al.Wei Zhang ... Huayue Lin
03 Feb 2025
Correction: Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.
Chao An ... Jianjun Han
British journal of cancer | VOL. -
Chao An, et. al.Chao An ... Jianjun Han
03 Feb 2025
Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study.
Rong Wang ... Ninghan Feng
British journal of cancer | VOL. -
Rong Wang, et. al.Rong Wang ... Ninghan Feng
03 Feb 2025
Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos.
Andrew Hartley ... Imran Ahmad
British journal of cancer | VOL. -
Andrew Hartley, et. al.Andrew Hartley ... Imran Ahmad
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.